News Focus
News Focus
Followers 59
Posts 7595
Boards Moderated 0
Alias Born 10/20/2014

Re: SanDiegoLiving post# 437551

Tuesday, 07/29/2025 10:01:23 PM

Tuesday, July 29, 2025 10:01:23 PM

Post# of 448139
Honestly, I would hope there is some grand master plan that Alex Denner is focused on.
However, I am disgusted by the botched share buyback plan that never happened. Some
hint from management that they have a strategic plan to develop the one-a-day version of
Vascepa. All of the past managements of Amarin have taken a great drug and laid it to waste.
When Marzac was going after the fraud management would not back him. How more stupid
could management at the time have been. China's approval of Vascep seems to never gain
any traction...The same for the rest of the world. If Denner were to have any confidence in
this company he would increase the stake held by Sarissa and then initiate a share buyback
program. Until management makes some concrete moves to show confidence in this company
the share price will simply languish. Why has management not stepped up to buy shares with
their own money? Until they do I will not get excited about anything AMRN says or does.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News